Elixxer Ltd - Asset Resilience Ratio

Latest as of December 2023: 0.00%

Elixxer Ltd (ELXR) has an Asset Resilience Ratio of 0.00% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Elixxer Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

CA$0.00

≈ $0.00 USD Cash + Short-term Investments

Total Assets

CA$2.81 Million

≈ $2.03 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2023)

This chart shows how Elixxer Ltd's Asset Resilience Ratio has changed over time. See what is Elixxer Ltd's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Elixxer Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Elixxer Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$0.00	0%
Total Liquid Assets	CA$0.00	0.00%

Asset Resilience Insights

Limited Liquidity: Elixxer Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company maintains a balanced mix of cash and short-term investments.

Elixxer Ltd Industry Peers by Asset Resilience Ratio

Compare Elixxer Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	1.96%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	8.47%

Annual Asset Resilience Ratio for Elixxer Ltd (2017–2023)

The table below shows the annual Asset Resilience Ratio data for Elixxer Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	0.00%	CA$0.00 ≈ $0.00	CA$2.81 Million ≈ $2.03 Million	--
2022-12-31	44.82%	CA$2.41 Million ≈ $1.74 Million	CA$5.37 Million ≈ $3.88 Million	-34.09pp
2021-12-31	78.91%	CA$13.28 Million ≈ $9.61 Million	CA$16.84 Million ≈ $12.18 Million	--
2020-12-31	0.00%	CA$0.00 ≈ $0.00	CA$20.81 Million ≈ $15.06 Million	--
2018-12-31	0.00%	CA$0.00 ≈ $0.00	CA$20.74 Million ≈ $15.00 Million	--
2017-12-31	24.65%	CA$677.24K ≈ $489.91K	CA$2.75 Million ≈ $1.99 Million	--

pp = percentage points

About Elixxer Ltd

V:ELXR Canada Drug Manufacturers - Specialty & Generic

Market Cap

$328.10K

CA$453.56K CAD

Market Cap Rank

#30685 Global

#1661 in Canada

Share Price

CA$0.04

Change (1 day)

+0.00%

52-Week Range

CA$0.04 - CA$1.15

All Time High

CA$99.00